Ventricular Assist Device Market Thrives on Lifesaving Technology and Growing Demand, Poised for US$ 20.6 Billion by 2033 - Persistence Market Research
09. Januar 2024 07:15 ET
|
Persistence Market Research
New York, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Ventricular Assist Devices Market was held at around US$ 2.7 Billion in 2023 and is expected to grow with a CAGR of 22.8% from...
Ventricular Assist Devices Market is estimated to surge ahead at a CAGR of 22.8% to reach US$ 20.6 Billion by the end of 2033, States Persistence Market Research
15. März 2023 08:54 ET
|
Persistence Market Research
New York, March 15, 2023 (GLOBE NEWSWIRE) -- The Ventricular Assist Devices Market revenues were estimated at US$ 2.3 Billion in 2022 and are anticipated to grow at a CAGR of 22.8% from 2023 to...
Ventricular Assist Devices Market to Expand at 11.2% CAGR from 2020 to 2027 - Report by Market Research Future (MRFR)
24. Juni 2021 12:52 ET
|
Market Research Future
New York, US, June 24, 2021 (GLOBE NEWSWIRE) -- Ventricular Assist Devices Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Ventricular Assist...
Ventricular Assist Devices Market to cross $3.5 billion by 2025: Global Market Insights, Inc.
29. Oktober 2019 04:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Oct. 29, 2019 (GLOBE NEWSWIRE) -- World ventricular assist devices market share is poised to surpass USD 3.5 billion by 2025; according to a new research report by Global...
Ventricular Assist Devices Market to cross $3.5 billion by 2025: Global Market Insights, Inc.
29. Oktober 2019 04:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Oct. 29, 2019 (GLOBE NEWSWIRE) -- World ventricular assist devices market share is poised to surpass USD 3.5 billion by 2025; according to a new research report by Global...
Ventricular Assist Devices Market worth over $2 billion by 2024: Global Market Insights, Inc.
04. Dezember 2018 05:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Germany dominated the Europe ventricular assist devices market and was valued over USD 106.7 million in the year 2017. According to the...
Advancements in Medical Devices Contributing to the Growth of Left Ventricular Assist Device Market to Grow at a CAGR of 10.5% during 2018-2024 : Energias Market Research Pvt. Ltd.
19. März 2018 08:40 ET
|
Energias Market Research
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- The global left ventricular assist device (LVADs) market is expected to grow significantly from USD 1,024 million in 2017 to USD 2,043 million in 2024,...
Mesoblast Receives FDA Regenerative Medicine Advanced Therapy Designation for Its Cell Therapy in Heart Failure Patients With Left Ventricular Assist Devices
21. Dezember 2017 06:00 ET
|
Mesoblast Limited
NEW YORK and MELBOURNE, Australia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that the United States Food and Drug Administration (FDA) has granted...
Mesoblast's Cell Therapy Strengthens Native Heart Function In Patients With End-Stage Heart Failure on Assisted Circulatory Support
18. November 2013 18:14 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Patients with end-stage or New York Heart Association (NYHA) class IV heart failure who receive a surgically implanted left...